Current controversies and challenges in allergic rhinitis management - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Expert Review of Clinical Immunology Année : 2015

Current controversies and challenges in allergic rhinitis management

David Price
  • Fonction : Auteur
Pete Smith
Peter Hellings
Nikos Papadopoulos
Wytske Fokkens
Ruth Murray
  • Fonction : Auteur
Alison Chisholm
  • Fonction : Auteur
Glenis K Scadding
  • Fonction : Auteur
  • PersonId : 938750
Phil Lieberman
  • Fonction : Auteur
Claus Bachert
Dermot Ryan


There are many obstacles in the path of effective allergy management, in general, and allergic rhinitis (AR) control, in particular. Chief among them are: insufficient symptom relief in some patients provided by some currently considered first-line AR treatments in real life; an over-reliance on randomized controlled trials to direct AR guideline recommendations; the need for a broader interpretation of the AR evidence base (to include randomized controlled trials and real-life studies); poorly designed and interpreted studies; and lack of an AR control concept and common language of control. These controversies are fully reviewed here and challenging solutions have been presented.

Dates et versions

hal-01952348 , version 1 (12-12-2018)



David Price, Pete Smith, Peter Hellings, Nikos Papadopoulos, Wytske Fokkens, et al.. Current controversies and challenges in allergic rhinitis management. Expert Review of Clinical Immunology, 2015, 11 (11), pp.1205-1217. ⟨10.1586/1744666X.2015.1081814⟩. ⟨hal-01952348⟩
196 Consultations
0 Téléchargements



Gmail Facebook X LinkedIn More